Short- and Long-term Outcomes of Postoperative Intrauterine Application of Hyaluronic Acid Gel: A Meta-analysis of Randomized Controlled Trials
- PMID: 35577245
- DOI: 10.1016/j.jmig.2022.05.006
Short- and Long-term Outcomes of Postoperative Intrauterine Application of Hyaluronic Acid Gel: A Meta-analysis of Randomized Controlled Trials
Abstract
Objective: To systematically evaluate the role of hyaluronic acid (HA) gel and its derivatives in the postoperative prevention of intrauterine adhesions (IUA) and to assess whether HA gel could improve the pregnancy rate.
Data sources: A structured search was performed in PubMed, Cochrane, Scopus, Web of Science, and Embase on February 2, 2022.
Methods of study selection: We chose medical subject headings and relevant terms from other articles for the database search. The following intervention was selected: HA gel or related derivatives vs placebo in randomized controlled trials (RCTs). The following outcomes were selected: the rate and severity of IUA after intrauterine operations and pregnancy rate. After the full-text screening, 12 articles were included in the final analysis. The study quality and risk of bias were assessed with the Cochrane tool (www.training.cochrane.org/handbook).
Tabulation, integration, and results: Data from 12 articles on 1579 patients were extracted and analyzed by 2 independent reviewers. According to the meta-analysis, HA gel could decrease the risk of IUA (risk ratio [RR], 0.50; 95% confidence interval [CI], 0.37-0.67; p = .005; I2 = 59%) after intrauterine operations. Subgroup analysis revealed a significant positive impact of HA gel on both groups receiving dilatation and curettage (RR, 0.42; 95% CI, 0.30-0.59; p = .86; I2 = 0) or hysteroscopic surgery (RR, 0.55; 95% CI, 0.38-0.80; p = .007; I2 = 66%). The sensitivity analysis showed that heterogeneity could be improved significantly by removing one study. The severity of IUA (mean difference = -0.92; 95% CI, -1.49 to -0.34; p <.00; I2 = 89%) was lower in the intervention group. Subgroup and sensitivity analyses did not significantly improve the heterogeneity. When the studies are classified by the volume of HA gel, 10 mL (RR, 0.40; 95% CI, 0.27-0.60; p = .96; I2 = 0) and 5 mL (RR, 0.34; 95% CI, 0.14-0.82; p = .36; I2 = 0) were effective in treating IUA. In contrast, HA gel <5 mL was not sufficient to prevent IUA (RR, 0.66; 95% CI, 0.43-1.01; p = .02; I2 = 71%; p = .05). The pregnancy rate was also improved by the use of HA gel (RR, 1.39; 95% CI, 1.13-1.72; p = .37, I2 = 0).
Conclusion: HA gel helps prevent IUA and decreases the severity of IUA after intrauterine surgery. A greater volume (≥5 mL) of HA gel is recommended to prevent IUA, according to this analysis. Moreover, HA gel can increase the pregnancy rate after intrauterine surgery. However, these conclusions should be interpreted with caution because of the inadequate quality of some RCTs with relatively small sample sizes and sample heterogeneity. Large RCTs are required to verify these conclusions in the future.
Keywords: Hyaluronic acid gel; Intrauterine adhesion; Meta-analysis.
Copyright © 2022 AAGL. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Meta-analysis of the use of hyaluronic acid gel to prevent intrauterine adhesions after miscarriage.Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:1-4. doi: 10.1016/j.ejogrb.2019.10.018. Epub 2019 Oct 22. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31731019 Review.
-
Meta-analysis on the use of hyaluronic acid gel to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis.Taiwan J Obstet Gynecol. 2019 Nov;58(6):731-736. doi: 10.1016/j.tjog.2019.09.002. Taiwan J Obstet Gynecol. 2019. PMID: 31759520 Review.
-
Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations.Exp Ther Med. 2020 Apr;19(4):2672-2678. doi: 10.3892/etm.2020.8483. Epub 2020 Feb 3. Exp Ther Med. 2020. PMID: 32256748 Free PMC article.
-
Efficacy of hyaluronic acid on the prevention of intrauterine adhesion and the improvement of fertility: A meta-analysis of randomized trials.Complement Ther Clin Pract. 2022 May;47:101575. doi: 10.1016/j.ctcp.2022.101575. Epub 2022 Mar 23. Complement Ther Clin Pract. 2022. PMID: 35349823 Review.
-
[Prevention of intrauterine adhesion with auto-crosslinked hyaluronic acid gel: a prospective, randomized, controlled clinical study].Zhonghua Fu Chan Ke Za Zhi. 2015 Jan;50(1):32-6. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 25877422 Clinical Trial. Chinese.
Cited by
-
Clinical study on 2 types of intrauterine stents with different thickness and hardness in the treatment of moderate-to-severe intrauterine adhesions.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Nov 28;47(11):1575-1585. doi: 10.11817/j.issn.1672-7347.2022.220340. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36481636 Free PMC article.
-
Intrauterine interventions options for preventing recurrence after hysteroscopic adhesiolysis: a systematic review and network meta-analysis of randomized controlled trials.Arch Gynecol Obstet. 2024 May;309(5):1847-1861. doi: 10.1007/s00404-024-07460-y. Epub 2024 Mar 17. Arch Gynecol Obstet. 2024. PMID: 38493418 Review.
-
Clinical evaluation of autologous platelet-rich plasma therapy for intrauterine adhesions: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2023 Jul 6;14:1183209. doi: 10.3389/fendo.2023.1183209. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37484965 Free PMC article.
-
ViSCNOVAS: A Novel Classification System for Hyaluronic Acid-Based Gels in Orthobiologic Products and Regenerative Medicine.Gels. 2024 Aug 2;10(8):510. doi: 10.3390/gels10080510. Gels. 2024. PMID: 39195039 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials